173 related articles for article (PubMed ID: 34928562)
1. A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics.
He L; Yu Y; Zhang L; He S; Yu W; Li L; Huang J; Li H
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):71-74. PubMed ID: 34928562
[TBL] [Abstract][Full Text] [Related]
2. Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.
Yang FD; Wang XQ; Liu XP; Zhao KX; Fu WH; Hao XR; Zhang XL; Huang GS; Qu SC; Bai JS; Huang XF; Kosten TR; Zhang XY
Psychopharmacology (Berl); 2011 Jul; 216(1):9-16. PubMed ID: 21301815
[TBL] [Abstract][Full Text] [Related]
3. QTc prolongation in patients with schizophrenia taking antipsychotics: Prevalence and risk factors.
Du W; Ge MW; Hu FH; Jia YJ; Zhao DY; Cheng YJ; Chen HL
J Psychopharmacol; 2023 Oct; 37(10):971-981. PubMed ID: 37534722
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of antipsychotics and QTc prolongation: a pilot study.
Høimark L; Uhrskov Sørensen L; Vukelic Andersen L
Nord J Psychiatry; 2020; 74(5):374-379. PubMed ID: 32105154
[No Abstract] [Full Text] [Related]
5. The QTc interval and its dispersion in patients receiving two atypical antipsychotics.
Correll CU; Frederickson AM; Figen V; Ginn-Scott EJ; Pantaleon Moya RA; Kane JM; Manu P
Eur Arch Psychiatry Clin Neurosci; 2009 Feb; 259(1):23-7. PubMed ID: 18574608
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics.
Lin CH; Chen MC; Wang SY; Lin CY
J Formos Med Assoc; 2004 Jun; 103(6):437-41. PubMed ID: 15278188
[TBL] [Abstract][Full Text] [Related]
7. QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009.
Xiang YT; Chiu HF; Ungvari GS; Correll CU; Lai KY; Wang CY; Si TM; Lee EH; He YL; Yang SY; Chong MY; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Tan CH; Shinfuku N
Hum Psychopharmacol; 2015 Mar; 30(2):94-9. PubMed ID: 25611192
[TBL] [Abstract][Full Text] [Related]
8. QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.
Spellmann I; Reinhard MA; Veverka D; Zill P; Obermeier M; Dehning S; Schennach R; Müller N; Möller HJ; Riedel M; Musil R
Eur Arch Psychiatry Clin Neurosci; 2018 Jun; 268(4):383-390. PubMed ID: 29429138
[TBL] [Abstract][Full Text] [Related]
9. QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy.
Elliott A; Mørk TJ; Højlund M; Christensen T; Jeppesen R; Madsen N; Viuff AG; Hjorth P; Nielsen JC; Munk-Jørgensen P
CNS Spectr; 2018 Aug; 23(4):278-283. PubMed ID: 28659221
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia.
Sankaranarayanan A; Kazi S; Andrade C
Schizophr Res; 2024 Jun; 268():145-149. PubMed ID: 37770378
[TBL] [Abstract][Full Text] [Related]
11. Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.
Camm AJ; Karayal ON; Meltzer H; Kolluri S; O'Gorman C; Miceli J; Tensfeldt T; Kane JM
CNS Drugs; 2012 Apr; 26(4):351-65. PubMed ID: 22452529
[TBL] [Abstract][Full Text] [Related]
12. QTc interval in a sample of long-term schizophrenia inpatients.
Ramos-Ríos R; Arrojo-Romero M; Paz-Silva E; Carballal-Calvo F; Bouzón-Barreiro JL; Seoane-Prado J; Codesido-Barcala R; Crespí-Armenteros A; Fernández-Pérez R; López-Moríñigo JD; Tortajada-Bonaselt I; Diaz FJ; de Leon J
Schizophr Res; 2010 Jan; 116(1):35-43. PubMed ID: 19892525
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
Glassman AH
J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
[TBL] [Abstract][Full Text] [Related]
14. Ziprasidone in the management of schizophrenia : the QT interval issue in context.
Taylor D
CNS Drugs; 2003; 17(6):423-30. PubMed ID: 12697001
[TBL] [Abstract][Full Text] [Related]
15. An analysis of QTc prolongation with atypical antipsychotic medications and selective serotonin reuptake inhibitors using a large ECG record database.
Park SI; An H; Kim A; Jang IJ; Yu KS; Chung JY
Expert Opin Drug Saf; 2016 Aug; 15(8):1013-9. PubMed ID: 27276059
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
Haddad PM; Anderson IM
Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study.
Correll CU; Harris J; Figen V; Kane JM; Manu P
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):365-8. PubMed ID: 21823910
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.
Czekalla J; Beasley CM; Dellva MA; Berg PH; Grundy S
J Clin Psychiatry; 2001 Mar; 62(3):191-8. PubMed ID: 11305706
[TBL] [Abstract][Full Text] [Related]
19. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
[TBL] [Abstract][Full Text] [Related]
20. QTc variability in schizophrenia patients treated with antipsychotics and healthy controls.
Rettenbacher MA; Eder-Ischia U; Bader A; Edlinger M; Hofer A; Hummer M; Kemmler G; Weiss EM; Hochleitner M; Fleischhacker WW
J Clin Psychopharmacol; 2005 Jun; 25(3):206-10. PubMed ID: 15876897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
